← All projects
Removing damaged cells

Rubedo RLS-1496 senescent-cell programme

Rubedo Life Sciences

If it works, it could remove or quiet damaged cells that build up with age and disturb the healthy cells around them.

WHAT IT IS TRYING TO CHANGE

What the project is doing

Rubedo RLS-1496 senescent-cell programme is being developed as part of the wider effort to prevent, delay or repair age-related decline.

What this could do for you

If it works, it could remove or quiet damaged cells that build up with age and disturb the healthy cells around them.

What has to happen next

The next checkpoint is whether the treatment is safe enough and shows enough biological activity to continue.

What could stop it

The study is mainly about safety and dose. It may not show whether people actually live longer or feel better.

WHERE IT STANDS

Current evidence and outlook

Rubedo RLS-1496 senescent-cell programme is being developed as part of the wider effort to prevent, delay or repair age-related decline.

Likely path

Often 5–10 years from broad availability, if safety and later studies succeed.

Why this estimate

Early human testing answers only part of what is needed.

Record checked: 2026-08-27

ORIGINAL EVIDENCE

Research details and sources

The sources below support the project record. RejuvAccess separately checks whether a practical route is open and worth pursuing.

  1. Rubedo — clinical news and June 2026 preliminary results
  2. Rubedo — RLS-1496 pipeline
  3. ClinicalTrials.gov — RLS-1496 study NCT07340697
MAKE IT PERSONAL

Could this matter for your situation?

Ask RejuvAccess to check the evidence, access route, cost and next step for you.

Start an access check